A B S T R A C T The effects of prostaglandins E2 and 12 on accumulation of [4C] aminopyrine and the generation of cyclic AMP by fractions of dispersed canine gastric mucosal cells, enriched in their content ofparietal cells, have been studied. The parietal cell content of the fractions was enriched to between 43 and 70% using an elutriator rotor. The accumulation of ['4C]aminopyrine was used as the index of parietal cell response to stimulation. Prostaglandin E2 (PGE2, 0.1 nM-0.1 mM) inhibited histamine stimulated aminopyrine uptake but did not block the response to carbachol, gastrin, or dibuturyl cyclic AMP. PGE2 did, however, inhibit aminopyrine uptake stimulated by carbachol and gastrin when the response to these agents was potentiated by histamine. PGE2 (0.1 nM-0.1 mM) inhibited histamine-stimulated cyclic AMP production in a dose-dependent fashion with maximal inhibition at 1 ,uM PGE2.
Prostacyclin also inhibited both histamine-stimulated aminopyrine accumulation and histamine-stimulated cyclic AMP production. In the absence of added histamine, PGE2 in concentrations above 1 puM and prostacyclin in concentrations above 10,uM stimulated cyclic AMP production, probably by acting on the nonparietal cells as shown in previous studies. These present data are consistent with the hypothesis that prostaglandins E2 and 12 inhibit the response of isolated parietal cells to histamine by specifically blocking histaminestimulated cyclic AMP production.
INTRODUCTION
Several members of the prostaglandin f:amily are synthesized by gastric mucosa (2, 3) and when given exogenously are capable of protecting gastric mucosa from ulcer and erosion formation (4) (5) (6) . Prostaglandins are potent inhibitors of acid secretion, inhibiting stimulation by histamine, gastrin, cholinergic stimuli, and food (2, 4, (7) (8) (9) (10) (11) . Prostacyclin (PGI2),' a newly identified metabolite of the prostaglandin precursor arachidonic acid, is formed by gastric mucosa (3) and, like the E and A group prostaglandins, is also a potent inhibitor of gastric acid secretion (12) (13) (14) . Prostaglandins, however, prevent ulcer formation by mechanisms in addition to inhibition of acid secretion, a property of prostaglandins that Robert (5) has termed "cytoprotection." A few of the proposed mechanisms that may account for cytoprotection are increased mucosal blood flow (15) , enhanced mucus production, bicarbonate secretion presumably by surface epithelial cells (16) , and possibly alterations in sodium flux (cf. 5). The present study, however, concerns the mechanisms involved in the inhibition of parietal cell function by prostaglandins E2 and 12.
In previous studies, histamine, gastrin, cholinergic agents, and cyclic AMP analogues were found to increase both oxygen consumption (17) and ['4C]aminopyrine accumulation (18) by parietal cells isolated from canine fundic mucosa. Stimulation by histamine, but not by carbachol or gastrin, was found to be accompanied by increased parietal cell generation of cyclic AMP (19) . Prostaglandin E2 (PGE2), which is known to stimulate cyclic AMP production by gastric mucosa (20, 21) , was found to increase cyclic AMP production predominantly in nonparietal cells, with at most a very small effect on parietal cells (22) . These observations with isolated mucosal cells did not resolve the question of the relation, if any, between the effects of PGE2 on cyclic AMP production and inhibition of acid secretion by PGE2. In the present study, the effects of PGE2 on parietal cell aminopyrine accumulation and cyclic AMP production have been examined during stimulation by a variety of agents alone and in combinations. Because PGI2 may be the most abundant prostaglandin produced by gastric mucosa, its effects on histamine-stimulated parietal cell activity and cyclic AMP formation have also been examined.
METHODS
Preparation ofcells and determination of [14C]aminopyrine (AP) uptake. Cells were isolated from canine fundic mucosa that had been completely separated from submucosa and then sequentially treated with crude collagenase and EDTA. These methods and the methods for determining AP uptake have been described in detail previously (17, 18) . The elutriator rotor, Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif. (17, 22) was used to prepare fractions enriched in parietal cell content (43-70%); these fractions were used for all of the subsequent studies.
Stimulants and the prostaglandins were added simultaneously to the cell suspension, which was kept at 4°C until incubated with AP at 37°C for 20 min. In each cell preparation, the AP accumulation was determined on triplicate samples of one or two incubations for each treatment condition. AP accumnulation was calculated as the ratio of the AP concentration in the parietal cell to that in the medium. After subtracting the basal accumulation ratio, each value was normalized by expressing it as the percentage ofthe accumulation ratio produced by a given concentration of the stimulant(s). The AP accumulation ratio to which each individual set of values was normalized is given in the appropriate figure legend.
Determination of cyclic AMP content. Cyclic AMP content was measured in cells that had been incubated for 15 min in 4 ml of the same Earles' balanced salt solution used for the AP studies (18) , at which time the test agents were added simultaneously in a volume of < 150 ,ul. The phosphodiesterase inhibitor 3-isobutyl, 1-methyl xanthine (IMX) was added to all of the cyclic AMP experiments to retard degradation of cyclic AMP. The incubation was terminated by transferring 3.5 ml of the cell suspension to a chilled tube containing trichloroacetic acid (final concentration, 5%), which was then frozen at -20°C. Upon thawing, [3H]cyclic AMP marker was added to each tube for determination of recovery and the suspension was centrifuged for 15 min at 3,000 g. The supernate was extracted four times with 5 ml of water-saturated ether. The water phase was then dried under a stream of air in a water bath at 650C and the residue resuspended in 1 ml of sodium acetate buffer (0.05 M, pH 6.2). Cyclic AMP content was then determined using the radioimmunoassay technique of Steiner et al. (23) as modified using acetylated cyclic AMP by Harper and Booker (24) . The applications of these methods have been described elsewhere (22) . In previous studies (22) , <15% of the total cyclic AMP content, either with IMX alone (0.1 mM) or stimulated by histamine (10 ,u M) or PGE2 (0.1 mM) plus IMX, was present in the supemate, and therefore the content of cyclic AMP in the present study has been determined on the entire cell suspension.
Cyclic AMP content was determined in triplicate for the one or two incubations for each treatment condition. The mean of these values was corrected for recovery and then expressed as the percentage of the response to a given concentration of stimulant. The amounts of cyclic AMP generated in picomoles per 106 cells per 5 min incubation for these given response points to which other values are normalized, are stated in the figure legends.
Statistical analyses. The statistical significance of differences was evaluated using Student's t test, with n equal to the number of cell preparations. Standard errors are depicted in the figures and given after the + sign in the text and figure legends. Materials AP (15.6, uCi/, umol) PGI2, as the sodium salt (25) was dissolved (10 mg/ml) in 1 M freshly prepared Tris buffer (pH 9.6) and stored for <2 h on ice; dilutions were made immediately before use in ice cold Earles' medium (pH 7.6). The highest Tris concentration added was 3.5 ,AM (final) and at this concentration, parietal cell functional responses were not altered. PGE2 was stored in ethanol (28 mg/ml, 80 mM) at -20°C, and diluted before use in Earles' medium. The highest concentration of ethanol delivered to a cell suspension was thus 0.13%. This concentration of ethanol did not alter either secretagogue stimulation of AP accumulation or the effects of PGE2 or histamine on cyclic AMP production. However, ethanol at 1.3% not only impaired secretagogue stimulation of AP acculmulation, but also blocked prostaglandin inhibition of histamine-stimutlated cyclic AMP production.
RESULTS

AP accumulation
PGE2 inhibition of histamine and IMX. PGE2 inhibited histamine (10 ,um) stimulation of AP accumulation in a dose-dependent fashion, with 1 ,uM PGE2 causing 91% inhibition of the response (Fig. 1A) . PGE2 also inhibited the response to l1gM histamine with a 10-g.tM IMX background (Fig. 1B) and the response to 100 ,M IMX as the sole stimulant (Fig. IC) . The concentration of PGE2 producing 50% inhibition of the response to histamine and IMX in each of these instainces was visually estimated at between 1 and 10 nM. PGE2 inhibited the reponse ofcanine parietal cells to histamine coniceintration-s from 1 to 100 ,tM (Fig. 2) .
Failure of PGE2 to inhibit the response to dibutyryl cyclic AMP (dbcAMP), carbachol, and gastrin. PGE2
(1 gM) failed to alter the dose-response relation for dbcAMP stimulation of AP accumulation (Fig. 3) . In separate experiments PGE2 in concentrations from 10 nM to 100 ,uM, failed to inhibit the response to 0.33 mM dbcAMP (n = 6, P > 0.2, data not illustrated). PGE2 (1 ,M) did not alter the dose-response relation for carbachol stimulation of AP accumulation (Fig. 4A) , nor did PGE2 between concentrations of 10 n M and 0.1 mM inhibit the response to 0.1 mM carbachol (n = 6, P > 0.2, data not illustrated). In addition, PGE2 did not appear to inhibit the very small response to 0.1 /iM gastrin (Fig. 5A) 2 The effect of PGE2 on the dose response for stimulation of AP uptake by histamine (H) in the presence of 10 .tM IMX. The dose-response relationship for histaminestimulated AP accumulation was tested without PGE2 and with three concentrations of PGE2. The data from four preparations were normalized to the response produced by 10 ,IM IMX (APARb = 60.5±+-32.0). Effects of PGE2 on AP accumulation during secretagogue interactions. When the AP accumulation in response to carbachol was potentiated by interaction with histamine, then PGE2 did inhibit this combined response; at the highest concentration of PGE2 (0.1 'Ja ), the residual effect was similar to that found with carbachol alone (Fig. 4B) . Similarly, when gastrin action was potentiated by interaction with histamine, PGE2 also inhibited the response to this combination, and at the highest concentration of PGE2 (0.1 ,uM), the residual response was equivalent to that found with gastrin alone (Fig. 5C ). In contrast, when the response to gastrin was potentiated by interaction with dbcAMP, not only did PGE2 fail to inhibit stimulation by this combination, but the highest concentration of PGE2 tested (0.1 mM) significantly enhanced the response histamine-potentiated responses to carbachol and gastrin was visually estimated at 10 nM. Effect of PGI2 on AP accumulation. Incubation of parietal cells with PGI2 produced a dose-related inhibition of histamine-stimulated AP accumulation (Fig. 6A) .
Cyclic AMP Production PGE2 inhibition of histamine-stimulated cyclic AMP production. PGE2 in concentrations between 0.1 nM and 1 ,utM inhibited stimulation of cyclic AMP production by 10 AtM histamine plus 0.1 mM IMX (Fig. 7) . Maximal inhibition was found with 1 AM PGE2 and at 0.1 mM less inhibition occurred (Fig. 7) . This lessened inhibition occurred in a concentration range that corresponded to the region in which PGE2 acting alone stimulated cyclic AMP production (Fig. 7) . In the presence of 100 ,uM IMX, PGE2 inhibited cyclic AMP production in response to histamine concentrations from 1 to 100 ,uM (Fig. 8) .
PGI2 inhibition of histamine-stimulated cyclic AMP production. Treatment of parietal cells with PGI2, in concentrations similar to those that inhibited histamine-stimulated AP accumulation, also produced a dose-related fall in histamine-elevated cyclic AMP levels (Fig. 6B ). In the absence of histamine, PGI2 produced elevation of cyclic AMP levels but these effects were only found at concentrations of 10 ,tM and higher (Fig. 6B) (19) . Major and Scholes (27) have also demonstrated in parietal cells isolated from canine mucosa that prostaglandins inhibit histamine-stimulated cyclic AMP production. PGE2 caused about 80% inhibition of the histamine effect with the ID50 of -10 nM; similar to findings in present study.
PGI2 was also capable of inhibiting both histaminestimulated AP accumulation and histamine-stimulated cyclic AMP production by parietal cells. The true potency of PGI2 is difficult to assess because of the very rapid breakdown to the far less active product 6-oxo-PGF1, (25) . Thus estimates of potency in a given system depend upon the mode of administration and the propensity for decomposition. Probably as a result of rapid decomposition in the present system, PGI2 was found to be much less potent in relation to PGE2 than had been found when antisecretory activity was tested in the dog (13) and the rat (12) using continuous intravenous infusion to compensate for rapid turnover. The present studies thus allow one to conclude that PGI2 inhibits histamine-stimulated parietal cell function and histamine-stimulated cyclic AMP production, but the comparative potency of PGI2 and PGE2 will require futher elucidation.
Prostaglandin actions on adenylate cyclase in gastric mucosa are complex, in that prostaglandins can both stimulate and inhibit cyclic AMP production. The present study and the work of Major and Scholes (27) indicate that the inhibitory effect of prostaglandins on histamine-activation of adenylate cyclase occur at low concentrations ofprostaglandins and may represent the physiologic mechanism by which prostaglandins inhibit acid secretion. On the other hand, it appears unlikely that the stimulatory effects of prostaglandins on adenylate cyclase are relevant to parietal cell function. In the present study, both PGE2 and PGI2, acting in the absence of histamine, stimulated cyclic AMP production. However, in accord with the findings in intact mucosa (20, 21, 28) , stimulation of cyclic AMP production was only found at concentrations of the prostaglandins >1 ,ulM and such high concentrations are unlikely to occur in vivo even under extreme conditions (29) . Furthermore, PGE2 appears to stimulate cyclic AMP production primarily in mucosal cells other than parietal cells themselves. Data supporting this latter point come from cell separation studies (22) in which an inverse correlation was found between PGE2-stimulated cyclic AMP production and the parietal cell content of the separated cell fractions. If high concentrations of PGE2 also stimulated cyclic AMP production in parietal cells, one might expect these same high concentrations to stimulate AP accumulation, for the reason that parietal cell function does appear to respond to cyclic AMP (18, 19 The ability of prostaglandins to both stimulate and inhibit cyclic AMP production in a given tissue has been described previously. Butcher and Baird (30) reported that PGE, inhibition ofepinephrine-stimulated lipolysis in fat tissue was paralleled by inhibition of epinephrine-stimulated cyclic AMP production. These effects of PGE, were found in a low concentration range (ID50 = 1 nM). However, at concentrations >1 uM, PGE, also increased cyclic AMP production on its own.
Although the inhibition of epinephrine action was also found in isolated fat cells, prostaglandin directly stimulated cyclic AMP production only in intact fat pads and not in the isolated adipocytes, indicating that this effect was probably on another cell type. The parallel of these findings to prostaglandin action on histamine-stimulated parietal cell function is striking.
There are other examples in the literature of inhibition of hormone-stimulated cyclic AMP function by prostaglandins (31, 32) . However, in certain cell types, such as platelets (33, 34) and heart tissue (35) , prostaglandins in concentrations in the nanomolar range may also stimulate adenylate cyclase, whereas in other cell types, this action is only found at 1,000-fold higher concentrations (36, 37) . Thus, depending on the cell type and the concentration tested, the effect of prostaglandins on adenylate cyclase may be stimulatory or inhibitory.
The mechanism of inhibition of acid secretion by prostaglandin has been perplexing because in vivo its effects are not specific in that stimulation by histamine, pentagastrin, vagal pathways, and food are all inhibited (2, 4, (7) (8) (9) (10) (11) . There are, however, in vitro studies that indicate that prostaglandin action may be specific for histamine. While studying frog mucosa, Way and Durbin (38) found that PGE, inhibited histamine-stimulated acid secretion but failed to inhibit the response to exogenous cyclic AMP. They therefore proposed that prostaglandin inhibition was specific for histamine, blocking activation of adenylate cyclase. Similarly, Main and Whittle (39) found in rat gastric mucosa that PGE, and PGE2 inhibited the response to histamine but not the small stimulation by dbcAMP alone. Furthermore, Glick (40) demonstrated that PGE, inhibited histamine-but not carbachol-stimulated chloride transport by polarized isolated parietal cells. The view that prostaglandins inhibit histamine-stimulated cyclic AMP production was not widely accepted both because the role of cyclic AMP as a mediator of histamine action on the parietal cell was highly disputed (41) , and because prostaglandins were shown to stimulate, not inhibit adenylate cyclase in gastric mucosa (20, 21) . However, this latter effect of prostaglandin occurs only with micromolar concentrations of prostaglandins both in intact mucosa and with isolated cells. The present findings with lower concentrations of prostaglandins and using isolated parietal cells confirmed the earlier hypothesis (38) that prostaglandins inhibit both histamine-stimulated parietal cell function and cyclic AMP generation. These present data, therefore, also support the view that histamine action on the parietal cell is closely linked to stimulation of cyclic AMP generation. Prostaglandin inhibition of histaminestimulated adenylate cyclase may be masked in intact mucosa because histamine-stimulated cyclic AMP generation in parietal cells may be only a small portion of total cyclic AMP content, whereas prostaglandins cause prominent stimulation of adenylate cyclase primarily in nonparietal cells. The use of lower prostaglandin concentrations may be helpful by reducing direct stimulation of adenylate cyclase. Furthermore, because PGE2 inhibition of histamine action is surmountable in the intact parietal cell,2 these effects m-ay not be clearly evident against maximal histaminestimulated activity.
In vivo, both histamine H2 receptor antagonists and prostaglandins inhibit all forms of acid secretion. However, in the isolated parietal cell, both of these inhibitors are specific against histamine, failing to block the action of cholinergic agents or gastrin. This apparent discrepancy between the in vivo and in vitro observations may however be explained by assuming that the parietal cell in the basal state in vivo is exposed to endogenous histamine in amounts sufficient to support potentiating interactions between stimulants. By isolating the parietal cell, this endogenous histamine background is largely removed, thereby allowing potentiation to be demonstrated when stimulants are added back in combination. When the actions of gastrin or carbachol are potentiated by interaction with histamine, then 1)oth prostaglandins and H2-blockers (42) display an apparent nonspecificity, reminiscent of that found in vivo and presumably resulting from specific inhibition of the histamine component of these interactions.
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